1. Books 17 items
    1. Koda-Kimble and Young's Applied therapeutics: the clinical use of drugs - Brian K. Alldredge, Mary Anne Koda-Kimble 2013

      Book Further

    2. Basic & clinical pharmacology 2015

      Book Further

    3. Clinical pharmacy and therapeutics 2019

      Book Further

    4. Disease management: a guide to clinical pharmacology - Michael D. Randall, Karen E. Neil 2016

      Book Further

    5. Disease management: a guide to clinical pharmacology | ebook - Michael D. Randall, Karen E. Neil 2016, ©2016 (electronic resource)

      Book 

    6. Drugs in use: case studies for pharmacists and prescribers 2013 (electronic resource)

      Book Further electronic resource, 5th edition

    7. BNF for children 2017-2018: September 2017-18 - British Medical Association, Royal Pharmaceutical Society of Great Britain, Royal College of Paediatrics and Child Health, Neonatal and Paediatric Pharmacists Group 2017 (electronic resource)

      Book Further

    8. Introduction to renal therapeutics 2008, ©2008 (electronic resource)

      Book Further electronic resource

    9. Introduction to renal therapeutics - Caroline Ashley, Clare Morlidge 2008

      Book Further

  2. Websites. 1 item
  3. Journals 1 item
    1. BRITISH NATIONAL FORMULARY | MedicinesComplete

      Journal Further Follow link for log in options on-campus and off-campus.

  4. Respiratory Resources 71 items
    1. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. - Bach PB; Health Outcomes Research Group, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 221, New York, NY 10021, USA.Brown CGelfand SEMcCrory DC 2001

      Article Optional

    2. Can a self-management programme delivered by a community pharmacist improve asthma control? A randomised trial. - Barbanel D; Institute of Community Health Sciences, Barts and the London, Queen Mary's School of Medicine and Dentistry, London E1 4NS, UK.Eldridge SGriffiths C 2003

      Article 

    3. New anti-inflammatory targets for chronic obstructive pulmonary disease. - Barnes PJ; National Heart and Lung Institute, Imperial College School of Medicine, Dovehouse Street, London SW3 6LY, UK. p.j.barnes@imperial.ac.uk 2013

      Article 

    4. Self-Management Behaviors in Older Adults with Asthma: Associations with Health Literacy. - Federman, Alex D.Wolf, Michael S.Sofianou, AnastasiaMartynenko, MelissaO'Connor, RachelHalm, Ethan A.Leventhal, HowardWisnivesky, Juan P. 2014

      Article 

    5. Effectiveness of Various Methods of Teaching Proper Inhaler Technique - Samantha Axtell, Seena Haines, Jamie Fairclough 04/2017

      Article 

    6. Stepping down inhaled corticosteroids in asthma: randomised controlled trial. - Hawkins G; Department of General Practice, University of Glasgow, Glasgow G12 0RR.McMahon ADTwaddle SWood SFFord IThomson NC 2003

      Article 

    7. Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD. - Johnson M; GlaxoSmithKline Research and Development, Uxbridge, Middlesex, UK. mj0859@glaxowellcome.co.ukRennard S 2001

      Article 

    8. Emergency oxygen use - R. O'Driscoll 18/10/2012

      Article 

    9. Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled Asthma - Stephen P. Peters, Susan J. Kunselman, Nikolina Icitovic, Wendy C. Moore 28/10/2010

      Article 

    10. Teaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trial. - Press VG; Section of Hospital Medicine, Department of Medicine, University of Chicago Medical Center, 5841 S. Maryland Ave, MC 5000, W328, Chicago, IL 60637, USA. vpress@medicine.bsd.uchicago.eduArora VMShah LMLewis SLCharbeneau JNaureckas ETKrishnan JA 2012

      Article 

    11. Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? - Sovani, Milind P.Whale, Christopher I.Oborne, JanetCooper, SueMortimer, KevinEkström, TommyTattersfield, Anne E.Harrison, Timothy W. 2008

      Article 

    12. Antibiotics for exacerbations of chronic obstructive pulmonary disease - Daniela J Vollenweider, Harish Jarrett, Claudia A Steurer-Stey, Judith Garcia-Aymerich

      Chapter 

    13. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease - Julia AE Walters, Joanne Ngie Qing Tang, Phillippa Poole, Richard Wood-Baker

      Chapter 

    14. Tiotropium Respimat Inhaler and the Risk of Death in COPD - Robert A. Wise, Antonio Anzueto, Daniel Cotton, Ronald Dahl 17/10/2013

      Article 

    15. Long-Term Maintenance of Pharmacists' Inhaler Technique Demonstration Skills. - Basheti, Iman A.; Armour, Carol L.; Reddel, Helen K.; Bosnic-Anticevich, Sinthia Z. 2009

      Article 

    16. Checklists for dry powder inhaler technique: a review and recommendations | Respiratory Care. 2013 - Iman A Basheti, Sinthia Z Bosnic-Anticevich, Carol L Armour and Helen K Reddel

      Article 

    17. Acute asthma. - FitzGerald, Mark 2001

      Article 

    18. Asthma: the condition and its diagnosis - Murphy A 2010

      Article  PLEASE NOTE: TO DOWNLOAD THIS ARTICLE click on the direct link below then scroll down the page to the full article pdf doc as described here: Supplementary information > cp201006_asthma_diagnosis-203.pdf

    19. Asthma: treatment and monitoring - Murphy A June 2010

      Article  PLEASE NOTE: TO DOWNLOAD THIS ARTICLE click on the direct link below then scroll down the page to the full article pdf doc as described here: Supplementary information > cp201006_asthma_treatment-209.pdf

  5. Digitised Resources 1 item
    1. High-Dose N-Acetylcysteine in Stable COPD:The 1-Year, Double-Blind, Randomized, Placebo-Controlled HIACE Study - Hoi Nam Tse; Luca Raiteri; King Ying Wong; Kwok Sang Yee; Lai Yun Ng; Ka Yan Wai; Ching Kong Loo; Ming Houng Chan 2013

      Article  DCS digitised article

  6. Cardiovascular Resources 208 items
    1. Rate- and Rhythm-Control Therapies in Patients With Atrial Fibrillation - Sana M. Al-Khatib, Nancy M. Allen LaPointe, Ranee Chatterjee, Matthew J. Crowley 03/06/2014

      Article 

    2. A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease. - Lamotte M; Health Economics and Disease Management, Brussels, Belgium. MLamotte@be.imshealth.comAnnemans LEvers TKubin M 2006

      Article 

    3. Optimal medical therapy with or without PCI for stable coronary disease. - Boden WE; Western New York Veterans Affairs Healthcare Network and Buffalo General Hospital-SUNY, Buffalo, NY 14203, USA. wboden@kaleidahealth.orgO'Rourke RATeo KKHartigan PMMaron DJKostuk WJKnudtson MDada MCasperson PHarris CLChaitman BRShaw LGosselin GNawaz STitle LMGau GBlaustein ASBooth DCBates ERSpertus JABerman DSMancini GBWeintraub WS 2007

      Article 

    4. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study. - Bruckert E; Department of Endocrinology, Hôpital de la Pitié-Salpétrière, Assistance Publique-Hôpitaux de Paris 83 Bd de L'Hôpital, 75 013, Paris, France. eric.bruckert@psl.ap-hop-paris.frHayem GDejager SYau CBégaud B 2005

      Article 

    5. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. - Dargie HJ; Department of Cardiology, Western Infirmary, G11 2NT, Glasgow, UK. H.Dargie@bio.gla.ac.uk 2001

      Article 

    6. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure - Cohn, J.N.1Johnson, G.Ziesche, S.Cobb, F.Francis, G.Tristani, F.Smith, R.Dunkman, W.B.Loeb, H.Wong, M.Bhat, G.Goldman, S.Fletcher, R.D.Doherty, J.Hughes, C.V.Carson, P.Cintron, G.Shabetai, R.Haakenson, C. 1991

      Article 

    7. Clinical Effects Of Anticoagulant Therapy In Suspected Acute Myocardial Infarction: Systematic Overview Of Randomised Trials - Collins, RoryMacMahon, StephenFlather, MarcusBaigent, ColinRemvig, LarsMortensen, SvendAppleby, PaulGodwin, JonYusuf, SalimPeto, Richard 1996

      Article 

    8. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. - de Lorgeril M; Explorations Fonctionnelles Cardiorespiratoires et Métaboliques, CHU de Saint-Etienne, France. lorgeril@univ-st-etienne.frSalen PMartin JLMonjaud IDelaye JMamelle N 1999

      Article 

    9. The effect of digoxin on mortality and morbidity in patients with heart failure. - Digitalis Investigation Group; Mount Sinai Medical Center, New York, NY 10029-6574, USA. 1997

      Article 

    10. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. - Eikelboom JW; Preventive Cardiology and Therapeutics Program, McMaster University, Hamilton, Canada.Anand SSMalmberg KWeitz JIGinsberg JSYusuf S 2000

      Article 

    11. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker, Héctor Bueno 14/07/2016

      Article 

    12. ACP Journal Club. Review: Aldosterone blockade reduces mortality in patients with left ventricular dysfunction. - Liu P; University of Toronto and Canadian Institutes of Health Research, Toronto, Ontario, Canada. 2009

      Article 

    13. Diuretics for heart failure - Rajaa F Faris, Marcus Flather, Henry Purcell, Philip A Poole-Wilson

      Chapter 

    14. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients - Flather, M.D.1,3,4Yusuf, S.1,2Pogue, J.1,2Køber, L.5Torp-Pedersen, C.5Pfeffer, M.6Braunwald, E.6Hall, A.7Ball, S.7Murray, G.8Moyé, L.9 2000

      Article 

    15. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study - Go, A.S.1Phillips, K.A.1Hylek, E.M.2Borowsky, L.H.2Singer, D.E.2Selby, J.V.3 1999

      Article  Note: you may be able to access link better via Firefox rather than Explorer or Google Chrome

    16. Atrial arrhythmias - Goodacre, S.Irons, R. 2002

      Article 

    17. Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction. - Grech ED; Health Sciences Centre and St Boniface Hospital, Winnipeg, Manitoba, Canada.Ramsdale DR 2003

      Article 

    18. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects. - Markham A; Adis International Limited, Mairangi Bay, Auckland, New Zealand.Plosker GLGoa KL 2000

      Article 

    19. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. - Hart RG; Department of Medicine (Neurology), University of Texas Health Science Center, San Antonio 78284, USA.Benavente OMcBride RPearce LA 1999

      Article 

    20. Exercise-based cardiac rehabilitation for coronary heart disease - Lindsey Anderson, David R Thompson, Neil Oldridge, Ann-Dorthe Zwisler

      Chapter 

    21. EANM/ESC guidelines for radionuclide imaging of cardiac function - B. Hesse, T. B. Lindhardt, W. Acampa, C. Anagnostopoulos 2008-4

      Article 

    22. Digitalis for treatment of heart failure in patients in sinus rhythm - William B Hood, Jr., Antonio L Dans, Gordon H Guyatt, Roman Jaeschke

      Chapter 

    23. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation - Craig T. January, L. Samuel Wann, Joseph S. Alpert, Hugh Calkins 12/2014

      Article 

    24. Novel drugs for treating angina. - Jones, Daniel A.Timmis, AdamWragg, Andrew 2013

      Article 

    25. Increased Mortality after Dronedarone Therapy for Severe Heart Failure - Lars Køber, Christian Torp-Pedersen, John J.V. McMurray, Ole Gøtzsche 19/06/2008

      Article 

    26. Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation - Stefan H. Hohnloser, Harry J.G.M. Crijns, Martin van Eickels, Christophe Gaudin 12/02/2009

      Article 

    27. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. - Lindholm LH; Department of Public Health and Clinical Medicine, Umeå University Hospital, Umeå, Sweden. Larsh.lindholm@fammed.umu.seCarlberg BSamuelsson O 2005

      Article 

    28. Management of atrial fibrillation. - Lip GY; University Department of Medicine, City Hospital, Birmingham, UK. g.y.h.lip@bham.ac.ukTse HF 2007

      Article 

    29. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARMPreserved Trial. - Yusuf, Salim1 yusufs@mcmaster.caPfeffer, Marc A.2Swedberg, Karl3Granger, Christopher B.4Held, Peter5McMurray, John J. V.6Michelson, Eric L.7Olofsson, Bertil5ostergren, Jan8 2003

      Article 

    30. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure - John J.V. McMurray, Milton Packer, Akshay S. Desai, Jianjian Gong 11/09/2014

      Article 

    31. Resistant hypertension - A. Myat, S. R. Redwood, A. C. Qureshi, J. A. Spertus 20/11/2012

      Article 

    32. Myocardial Infarction National Audit Project. How the NHS manages heart attacks. Eleventh public report April 2014 – March 2014. Accessed via:https://www.ucl.ac.uk/nicor/audits/minap/documents/annual_reports/minap-public-report-2014

    33. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. - Nissen SE; Department of Cardiovascular Medicine, Cleveland Clinic Lerner School of Medicine, Cleveland, Ohio 44195, USA. nissens@ccf.orgNicholls SJSipahi ILibby PRaichlen JSBallantyne CMDavignon JErbel RFruchart JCTardif JCSchoenhagen PCrowe TCain VWolski KGoormastic MTuzcu EM 2006

      Article 

    34. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. - Yusuf S; Department of Medicine, McMaster University and Hamilton Health Sciences, McMaster Clinic, Hamilton General Hospital, Hamilton, Ontario, Canada. yusufs@mcmaster.caMehta SRChrolavicius SAfzal RPogue JGranger CBBudaj APeters RJBassand JPWallentin LJoyner CFox KA 2006

      Article 

    35. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction - Patrick T. O'Gara, Frederick G. Kushner, Deborah D. Ascheim, Donald E. Casey 01/2013

      Article 

    36. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. - Packer M; College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. mp65@columbia.eduFowler MBRoecker EBCoats AJKatus HAKrum HMohacsi PRouleau JLTendera MStaiger CHolcslaw TLAmann-Zalan IDeMets DL 2002

      Article 

    37. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure - Packer, M.1Armstrong, P.W.2Massie, B.M.3Rydén, L.4Uretsky, B.F.5Poole-Wilson, P.A.6Cleland, J.G.F.Horowitz, J.D.Thygesen, K. 1999

      Article 

    38. Acute coronary syndromes without ST segment elevation. - Peters RJ; Department of Cardiology, Academic Medical Center, PO Box 22660, Amsterdam 1100, Netherlands. r.j.peters@amc.uva.nlMehta SYusuf S 2007

      Article 

    39. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. - Pfeffer MA; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.Braunwald EMoyé LABasta LBrown EJ JrCuddy TEDavis BRGeltman EMGoldman SFlaker GCet. al. 1992

      Article 

    40. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. - Pfeffer MA; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA. mpfeffer@rics.bwh.harvard.eduMcMurray JJVelazquez EJRouleau JLKøber LMaggioni APSolomon SDSwedberg KVan de Werf FWhite HLeimberger JDHenis MEdwards SZelenkofske SSellers MACaliff RM 2003

      Article 

    41. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. - Pfeffer MA; Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. mpfeffer@rics.bwh.harvard.eduSwedberg KGranger CBHeld PMcMurray JJMichelson ELOlofsson BOstergren JYusuf SPocock S 2003

      Article 

    42. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. - Pitt B; Division of Cardiology, University of Michigan School of Medicine, Ann Arbor 48109-0366, USA. b.pitt@umich.eduPoole-Wilson PASegal RMartinez FADickstein KCamm AJKonstam MARiegger GKlinger GHNeaton JSharma DThiyagarajan B 2000

      Article 

    43. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. - Pitt B; University of Michigan, Ann Arbor, USA. bpitt@umich.eduRemme WZannad FNeaton JMartinez FRoniker BBittman RHurley SKleiman JGatlin M 2003

      Article 

    44. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. - Pitt B; University of Michigan School of Medicine, Ann Arbor, Michigan 48109, USA. bpitt@med.umich.eduWhite HNicolau JMartinez FGheorghiade MAschermann Mvan Veldhuisen DJZannad FKrum HMukherjee RVincent J 2005

      Article 

    45. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. - Pitt B; Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor, USA.Zannad FRemme WJCody RCastaigne APerez APalensky JWittes J 1999

      Article 

    46. New NICE guidelines for hypertension - L. D. Ritchie, N. C. Campbell, P. Murchie 07/09/2011

      Article 

    47. Paradigm Shifts in Heart-Failure Therapy — A Timeline - Chana A. Sacks, John A. Jarcho, Gregory D. Curfman 11/09/2014

      Article 

    48. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. - Sacks FM; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.Pfeffer MAMoye LARouleau JLRutherford JDCole TGBrown LWarnica JWArnold JMWun CCDavis BRBraunwald E 1996

      Article 

    49. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. - Pfeffer MA; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.Braunwald EMoyé LABasta LBrown EJ JrCuddy TEDavis BRGeltman EMGoldman SFlaker GCet. al. 1992

      Article 

    50. Bivalirudin during Primary PCI in Acute Myocardial Infarction - Gregg W. Stone, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z. Peruga 22/05/2008

      Article 

    51. Meta-analysis of randomized trials comparing enoxaparin versus unfractionated heparin as adjunctive therapy to fibrinolysis in ST-elevation acute myocardial infarction. - Théroux P; Department of Medicine, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada. theroux@ICM.umontreal.caWelsh RC 2003

      Article 

    52. Aspirin, heparin, or both to treat unstable angina - Spodick, D.H.Bashein, G.Counts, R.B.Misbach, G.A.Theroux, P. 1989

      Article 

    53. Universal definition of myocardial infarction. - Thygesen KAlpert JSWhite HDJaffe ASApple FSGalvani MKatus HANewby LKRavkilde JChaitman BClemmensen PMDellborg MHod HPorela PUnderwood RBax JJBeller GABonow RVan der Wall EEBassand JPWijns WFerguson TBSteg PGUretsky BFWilliams DOArmstrong PWAntman EMFox KAHamm CWOhman EMSimoons MLPoole-Wilson PAGurfinkel EPLopez-Sendon JLPais PMendis SZhu JRWallentin LCFernández-Avilés FFox KMParkhomenko ANPriori SGTendera MVoipio-Pulkki LMVahanian ACamm AJDe Caterina RDean VDickstein KFilippatos GFunck-Brentano CHellemans IKristensen SDMcGregor KSechtem USilber STendera MWidimsky PZamorano JLMorais JBrener SHarrington RMorrow DLim MMartinez-Rios MASteinhubl SLevine GNGibler WBGoff DTubaro MDudek DAl-Attar N 2007

      Article 

    54. Diagnosis and management of supraventricular tachycardia. - Whinnett, Zachary I.Afzal Sohaib, S. M.Davies, D. Wyn 2012

      Article 

    55. Prasugrel versus clopidogrel in patients with acute coronary syndromes. - Wiviott SD; Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.Braunwald EMcCabe CHMontalescot GRuzyllo WGottlieb SNeumann FJArdissino DDe Servi SMurphy SARiesmeyer JWeerakkody GGibson CMAntman EM 2007

      Article 

    56. Beta-blockers for hypertension - Charles S Wiysonge, Hazel A Bradley, Jimmy Volmink, Bongani M Mayosi

      Chapter 

    57. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. - Yusuf S; Pfeffer MA; Swedberg K; Granger CB; Held P; McMurray JJV; Michelson EL; Olofsson B; Östergren J 2003

      Article 

    58. Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms - Faiez Zannad, John J.V. McMurray, Henry Krum, Dirk J. van Veldhuisen 06/01/2011

      Article